ArticleInflammation2019

Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Protects Blood-Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway.

Yonglin Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.